JP2008528519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008528519A5 JP2008528519A5 JP2007552413A JP2007552413A JP2008528519A5 JP 2008528519 A5 JP2008528519 A5 JP 2008528519A5 JP 2007552413 A JP2007552413 A JP 2007552413A JP 2007552413 A JP2007552413 A JP 2007552413A JP 2008528519 A5 JP2008528519 A5 JP 2008528519A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- methyl
- thiophen
- phenyl
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 34
- 125000000217 alkyl group Chemical group 0.000 claims 32
- 125000005843 halogen group Chemical group 0.000 claims 21
- -1 3,5-difluoro-pyridin-4-ylcarbamoyl Chemical group 0.000 claims 18
- 125000003545 alkoxy group Chemical group 0.000 claims 17
- 125000004438 haloalkoxy group Chemical group 0.000 claims 16
- 125000001188 haloalkyl group Chemical group 0.000 claims 16
- 125000001072 heteroaryl group Chemical group 0.000 claims 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 16
- 125000000623 heterocyclic group Chemical group 0.000 claims 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 10
- 125000003710 aryl alkyl group Chemical group 0.000 claims 9
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 239000012453 solvate Substances 0.000 claims 9
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 9
- 125000000547 substituted alkyl group Chemical group 0.000 claims 9
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 9
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 9
- 125000003107 substituted aryl group Chemical group 0.000 claims 8
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 7
- 230000002401 inhibitory effect Effects 0.000 claims 7
- 210000004027 cell Anatomy 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 6
- 238000000338 in vitro Methods 0.000 claims 5
- 102000004310 Ion Channels Human genes 0.000 claims 4
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 230000005931 immune cell recruitment Effects 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- SCRHWKOZSWUPKR-UHFFFAOYSA-N 3-methyl-n-[5-[2-methyl-5-(1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2OC=NN=2)C=C1C(S1)=CC=C1NC(=O)C1=CC=NC=C1C SCRHWKOZSWUPKR-UHFFFAOYSA-N 0.000 claims 2
- SZUVFRSOGIBPNO-UHFFFAOYSA-N 5-(5-carbamoyl-2-methylphenyl)-n-(2,6-difluorophenyl)thiophene-2-carboxamide Chemical compound CC1=CC=C(C(N)=O)C=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 SZUVFRSOGIBPNO-UHFFFAOYSA-N 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 210000003719 b-lymphocyte Anatomy 0.000 claims 2
- 210000003630 histaminocyte Anatomy 0.000 claims 2
- ACGGWEQWSHHHPS-UHFFFAOYSA-N methyl 3-chloro-4-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]benzoate Chemical compound ClC1=CC(C(=O)OC)=CC=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 ACGGWEQWSHHHPS-UHFFFAOYSA-N 0.000 claims 2
- BAEBBDIFQSEKMY-UHFFFAOYSA-N methyl 4-methyl-3-[5-[(3-methylpyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound COC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2)C)=C1 BAEBBDIFQSEKMY-UHFFFAOYSA-N 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- DFFBRMLHLXNTBV-UHFFFAOYSA-N propyl 4-chloro-3-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]benzoate Chemical compound CCCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CC=CC=2F)F)=C1 DFFBRMLHLXNTBV-UHFFFAOYSA-N 0.000 claims 2
- RMTLHQQETULZDK-UHFFFAOYSA-N 2,6-difluoro-n-[5-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]thiophen-2-yl]benzamide Chemical compound CC1=CC=C(C=2OC=CN=2)C=C1C(S1)=CC=C1NC(=O)C1=C(F)C=CC=C1F RMTLHQQETULZDK-UHFFFAOYSA-N 0.000 claims 1
- UELRFSJDXDLMOI-UHFFFAOYSA-N 2,6-difluoro-n-[5-[3-(trifluoromethyl)phenyl]thiophen-2-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC=C(C=2C=C(C=CC=2)C(F)(F)F)S1 UELRFSJDXDLMOI-UHFFFAOYSA-N 0.000 claims 1
- MDHWZJUMDNYPNM-UHFFFAOYSA-N 2-methoxyethyl 3-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]-4-methylbenzoate Chemical compound COCCOC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CC=CC=2F)F)=C1 MDHWZJUMDNYPNM-UHFFFAOYSA-N 0.000 claims 1
- HPOVNSVWDXOZEN-UHFFFAOYSA-N 2-methoxyethyl 3-[5-[(3,5-difluoropyridin-4-yl)carbamoyl]thiophen-2-yl]-4-methylbenzoate Chemical compound COCCOC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2F)F)=C1 HPOVNSVWDXOZEN-UHFFFAOYSA-N 0.000 claims 1
- XJKYXJZNGKCQAZ-UHFFFAOYSA-N 2-methoxyethyl 3-chloro-4-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]benzoate Chemical compound ClC1=CC(C(=O)OCCOC)=CC=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 XJKYXJZNGKCQAZ-UHFFFAOYSA-N 0.000 claims 1
- OIAGDNSHPPQUJO-UHFFFAOYSA-N 2-methoxyethyl 4-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]-3-methylbenzoate Chemical compound CC1=CC(C(=O)OCCOC)=CC=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 OIAGDNSHPPQUJO-UHFFFAOYSA-N 0.000 claims 1
- ZAHFPKWOQJHYTI-UHFFFAOYSA-N 2-methoxyethyl 4-chloro-3-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]benzoate Chemical compound COCCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CC=CC=2F)F)=C1 ZAHFPKWOQJHYTI-UHFFFAOYSA-N 0.000 claims 1
- TZGJAIZYYKTUAY-UHFFFAOYSA-N 2-methoxyethyl 4-chloro-3-[5-[(3,5-difluoropyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound COCCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2F)F)=C1 TZGJAIZYYKTUAY-UHFFFAOYSA-N 0.000 claims 1
- OLTLNUWCRQNFDV-UHFFFAOYSA-N 2-methoxyethyl 4-chloro-3-[5-[(3-methylpyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound COCCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2)C)=C1 OLTLNUWCRQNFDV-UHFFFAOYSA-N 0.000 claims 1
- XCRYJKQSYMEMPM-UHFFFAOYSA-N 2-methoxyethyl 4-methyl-3-[5-[(3-methylpyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound COCCOC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2)C)=C1 XCRYJKQSYMEMPM-UHFFFAOYSA-N 0.000 claims 1
- YKVCQIOABFYYHR-UHFFFAOYSA-N 3,5-difluoro-n-[5-[2-methyl-5-(1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2OC=NN=2)C=C1C(S1)=CC=C1NC(=O)C1=C(F)C=NC=C1F YKVCQIOABFYYHR-UHFFFAOYSA-N 0.000 claims 1
- HYJANQFYIOQISJ-UHFFFAOYSA-N 3,5-difluoro-n-[5-[2-methyl-5-(1,3,4-thiadiazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2SC=NN=2)C=C1C(S1)=CC=C1NC(=O)C1=C(F)C=NC=C1F HYJANQFYIOQISJ-UHFFFAOYSA-N 0.000 claims 1
- FWPVEECGGXZVAM-UHFFFAOYSA-N 3,5-difluoro-n-[5-[2-methyl-5-(1,3-oxazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2OC=CN=2)C=C1C(S1)=CC=C1NC(=O)C1=C(F)C=NC=C1F FWPVEECGGXZVAM-UHFFFAOYSA-N 0.000 claims 1
- JNNKPLGLXGSHAC-UHFFFAOYSA-N 3,5-difluoro-n-[5-[2-methyl-5-(1,3-thiazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2SC=CN=2)C=C1C(S1)=CC=C1NC(=O)C1=C(F)C=NC=C1F JNNKPLGLXGSHAC-UHFFFAOYSA-N 0.000 claims 1
- NTSOTTUZKUTNQU-UHFFFAOYSA-N 3-fluoro-n-[5-[2-methyl-5-(1,2-oxazol-5-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2ON=CC=2)C=C1C(S1)=CC=C1NC(=O)C1=CC=NC=C1F NTSOTTUZKUTNQU-UHFFFAOYSA-N 0.000 claims 1
- PTEJNWGOBSKDCI-UHFFFAOYSA-N 3-fluoro-n-[5-[2-methyl-5-(1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2OC=NN=2)C=C1C(S1)=CC=C1NC(=O)C1=CC=NC=C1F PTEJNWGOBSKDCI-UHFFFAOYSA-N 0.000 claims 1
- NQVOKZGDLMVMOE-UHFFFAOYSA-N 3-fluoro-n-[5-[2-methyl-5-(1,3,4-thiadiazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2SC=NN=2)C=C1C(S1)=CC=C1NC(=O)C1=CC=NC=C1F NQVOKZGDLMVMOE-UHFFFAOYSA-N 0.000 claims 1
- SCHJWFVIHDUIDE-UHFFFAOYSA-N 3-fluoro-n-[5-[2-methyl-5-(1,3-thiazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2SC=CN=2)C=C1C(S1)=CC=C1NC(=O)C1=CC=NC=C1F SCHJWFVIHDUIDE-UHFFFAOYSA-N 0.000 claims 1
- HMTVKTCKCSRNSG-UHFFFAOYSA-N 3-methyl-n-[5-[2-methyl-5-(1,2-oxazol-5-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2ON=CC=2)C=C1C(S1)=CC=C1NC(=O)C1=CC=NC=C1C HMTVKTCKCSRNSG-UHFFFAOYSA-N 0.000 claims 1
- JSLGZZWANSGFFA-UHFFFAOYSA-N 3-methyl-n-[5-[2-methyl-5-(1,3-thiazol-2-yl)phenyl]thiophen-2-yl]pyridine-4-carboxamide Chemical compound CC1=CC=C(C=2SC=CN=2)C=C1C(S1)=CC=C1NC(=O)C1=CC=NC=C1C JSLGZZWANSGFFA-UHFFFAOYSA-N 0.000 claims 1
- RLCIPEANWMGUII-UHFFFAOYSA-N 5-(5-bromo-2-methoxypyridin-3-yl)-n-(2,6-difluorophenyl)thiophene-2-carboxamide Chemical compound COC1=NC=C(Br)C=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 RLCIPEANWMGUII-UHFFFAOYSA-N 0.000 claims 1
- CNPMNPDDRZQEHW-UHFFFAOYSA-N 5-(5-bromo-2-methoxypyridin-3-yl)-n-(3,5-difluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound COC1=NC=C(Br)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2F)F)S1 CNPMNPDDRZQEHW-UHFFFAOYSA-N 0.000 claims 1
- GRKXGTHICDNIBR-UHFFFAOYSA-N 5-(5-bromo-2-methoxypyridin-3-yl)-n-(3-fluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound COC1=NC=C(Br)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)F)S1 GRKXGTHICDNIBR-UHFFFAOYSA-N 0.000 claims 1
- ICGNIEKBYLVFFF-UHFFFAOYSA-N 5-(5-bromo-2-methoxypyridin-3-yl)-n-(3-methylpyridin-4-yl)thiophene-2-carboxamide Chemical compound COC1=NC=C(Br)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)C)S1 ICGNIEKBYLVFFF-UHFFFAOYSA-N 0.000 claims 1
- HDQZPHBCASKWMW-UHFFFAOYSA-N 5-(5-carbamoyl-2-methylphenyl)-n-(3,5-difluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound CC1=CC=C(C(N)=O)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2F)F)S1 HDQZPHBCASKWMW-UHFFFAOYSA-N 0.000 claims 1
- YLNLHLZSKRNCJH-UHFFFAOYSA-N 5-(5-carbamoyl-2-methylphenyl)-n-(3-fluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound CC1=CC=C(C(N)=O)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)F)S1 YLNLHLZSKRNCJH-UHFFFAOYSA-N 0.000 claims 1
- GNYSHBLOQSPQCW-UHFFFAOYSA-N 5-(5-carbamoyl-2-methylphenyl)-n-(3-methylpyridin-4-yl)thiophene-2-carboxamide Chemical compound CC1=CC=C(C(N)=O)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)C)S1 GNYSHBLOQSPQCW-UHFFFAOYSA-N 0.000 claims 1
- XXRNWZQWAGYWQG-UHFFFAOYSA-N 5-(5-chloro-2-methoxypyridin-3-yl)-n-(2,6-difluorophenyl)thiophene-2-carboxamide Chemical compound COC1=NC=C(Cl)C=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 XXRNWZQWAGYWQG-UHFFFAOYSA-N 0.000 claims 1
- JRUGWMFEMJFCEK-UHFFFAOYSA-N 5-(5-chloro-2-methoxypyridin-3-yl)-n-(3,5-difluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound COC1=NC=C(Cl)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2F)F)S1 JRUGWMFEMJFCEK-UHFFFAOYSA-N 0.000 claims 1
- ZDLMXOGDJFFDLU-UHFFFAOYSA-N 5-(5-chloro-2-methoxypyridin-3-yl)-n-(3-fluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound COC1=NC=C(Cl)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)F)S1 ZDLMXOGDJFFDLU-UHFFFAOYSA-N 0.000 claims 1
- SBKWIGZHNKHPNS-UHFFFAOYSA-N 5-(5-chloro-2-methoxypyridin-3-yl)-n-(3-methylpyridin-4-yl)thiophene-2-carboxamide Chemical compound COC1=NC=C(Cl)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)C)S1 SBKWIGZHNKHPNS-UHFFFAOYSA-N 0.000 claims 1
- PCKSUQPUEASMEU-UHFFFAOYSA-N 5-(5-cyano-2-methylphenyl)-n-(3,5-difluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound CC1=CC=C(C#N)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2F)F)S1 PCKSUQPUEASMEU-UHFFFAOYSA-N 0.000 claims 1
- AYBBZFKTQHXGRA-UHFFFAOYSA-N 5-(5-cyano-2-methylphenyl)-n-(3-fluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound CC1=CC=C(C#N)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)F)S1 AYBBZFKTQHXGRA-UHFFFAOYSA-N 0.000 claims 1
- RKWCKMRWRMBMHD-UHFFFAOYSA-N 5-(5-cyano-2-methylphenyl)-n-(3-methylpyridin-4-yl)thiophene-2-carboxamide Chemical compound CC1=CC=C(C#N)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)C)S1 RKWCKMRWRMBMHD-UHFFFAOYSA-N 0.000 claims 1
- ZYPDOLOIVUQBHA-UHFFFAOYSA-N 5-[2-chloro-5-(trifluoromethyl)phenyl]-n-(2,6-difluorophenyl)thiophene-2-carboxamide Chemical compound FC1=CC=CC(F)=C1NC(=O)C1=CC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)S1 ZYPDOLOIVUQBHA-UHFFFAOYSA-N 0.000 claims 1
- GZQRIUNYAKGDOX-UHFFFAOYSA-N 5-[2-chloro-5-(trifluoromethyl)phenyl]-n-(3-methylpyridin-4-yl)thiophene-2-carboxamide Chemical compound CC1=CN=CC=C1NC(=O)C1=CC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)S1 GZQRIUNYAKGDOX-UHFFFAOYSA-N 0.000 claims 1
- XBWNZVFKRWKSBP-UHFFFAOYSA-N 5-[2-ethyl-5-(trifluoromethyl)phenyl]-n-(3-fluoropyridin-4-yl)thiophene-2-carboxamide Chemical compound CCC1=CC=C(C(F)(F)F)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)F)S1 XBWNZVFKRWKSBP-UHFFFAOYSA-N 0.000 claims 1
- JYQDNGRDKIYQQC-UHFFFAOYSA-N 5-[2-ethyl-5-(trifluoromethyl)phenyl]-n-(3-methylpyridin-4-yl)thiophene-2-carboxamide Chemical compound CCC1=CC=C(C(F)(F)F)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)C)S1 JYQDNGRDKIYQQC-UHFFFAOYSA-N 0.000 claims 1
- OKDINCQPRYXHSL-UHFFFAOYSA-N 5-[5-(furan-2-yl)-2-methoxypyridin-3-yl]-n-(3-methylpyridin-4-yl)thiophene-2-carboxamide Chemical compound COC1=NC=C(C=2OC=CC=2)C=C1C(S1)=CC=C1C(=O)NC1=CC=NC=C1C OKDINCQPRYXHSL-UHFFFAOYSA-N 0.000 claims 1
- FDQOESXHIHKIGV-UHFFFAOYSA-N 5-[5-(furan-3-yl)-2-methoxypyridin-3-yl]-n-(3-methylpyridin-4-yl)thiophene-2-carboxamide Chemical compound COC1=NC=C(C2=COC=C2)C=C1C(S1)=CC=C1C(=O)NC1=CC=NC=C1C FDQOESXHIHKIGV-UHFFFAOYSA-N 0.000 claims 1
- VSBQYZXBNQEHLV-UHFFFAOYSA-N ClC1(C(C=CC=C1)C1=CC=C(S1)NC(C1=C(C=NC=C1)C)=O)C=1OC=NN1 Chemical compound ClC1(C(C=CC=C1)C1=CC=C(S1)NC(C1=C(C=NC=C1)C)=O)C=1OC=NN1 VSBQYZXBNQEHLV-UHFFFAOYSA-N 0.000 claims 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 208000029462 Immunodeficiency disease Diseases 0.000 claims 1
- 108090000176 Interleukin-13 Proteins 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 108090000978 Interleukin-4 Proteins 0.000 claims 1
- 108010002616 Interleukin-5 Proteins 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 230000016396 cytokine production Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- VTTVLIMPVVYGMM-UHFFFAOYSA-N ethyl 3-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]-4-methylbenzoate Chemical compound CCOC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CC=CC=2F)F)=C1 VTTVLIMPVVYGMM-UHFFFAOYSA-N 0.000 claims 1
- VADOEKDINFXHTJ-UHFFFAOYSA-N ethyl 4-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]-3-methylbenzoate Chemical compound CC1=CC(C(=O)OCC)=CC=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 VADOEKDINFXHTJ-UHFFFAOYSA-N 0.000 claims 1
- IYNWLRQDGPVPGP-UHFFFAOYSA-N ethyl 4-chloro-3-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]benzoate Chemical compound CCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CC=CC=2F)F)=C1 IYNWLRQDGPVPGP-UHFFFAOYSA-N 0.000 claims 1
- ZSNNOVGLLCRCKD-UHFFFAOYSA-N ethyl 4-chloro-3-[5-[(3,5-difluoropyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound CCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2F)F)=C1 ZSNNOVGLLCRCKD-UHFFFAOYSA-N 0.000 claims 1
- DEJAQEQQWYEFPN-UHFFFAOYSA-N ethyl 4-chloro-3-[5-[(3-methylpyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound CCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2)C)=C1 DEJAQEQQWYEFPN-UHFFFAOYSA-N 0.000 claims 1
- HXFXAPUMGFSCQK-UHFFFAOYSA-N ethyl 4-methyl-3-[5-[(3-methylpyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound CCOC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2)C)=C1 HXFXAPUMGFSCQK-UHFFFAOYSA-N 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 230000007813 immunodeficiency Effects 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- GQZXIYHNNGWDGX-UHFFFAOYSA-N methyl 3-[5-[(2,6-difluorobenzoyl)amino]thiophen-2-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(C=2SC(NC(=O)C=3C(=CC=CC=3F)F)=CC=2)=C1 GQZXIYHNNGWDGX-UHFFFAOYSA-N 0.000 claims 1
- CYEJEUFHAKJVMF-UHFFFAOYSA-N methyl 3-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CC=CC=2F)F)=C1 CYEJEUFHAKJVMF-UHFFFAOYSA-N 0.000 claims 1
- ORUKKECDBDGFIM-UHFFFAOYSA-N methyl 3-[5-[(3,5-difluoropyridin-4-yl)carbamoyl]thiophen-2-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2F)F)=C1 ORUKKECDBDGFIM-UHFFFAOYSA-N 0.000 claims 1
- REQQGAUMSBGJPI-UHFFFAOYSA-N methyl 4-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]-3-methylbenzoate Chemical compound CC1=CC(C(=O)OC)=CC=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 REQQGAUMSBGJPI-UHFFFAOYSA-N 0.000 claims 1
- QFLYFAOOVUOQHD-UHFFFAOYSA-N methyl 4-chloro-3-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CC=CC=2F)F)=C1 QFLYFAOOVUOQHD-UHFFFAOYSA-N 0.000 claims 1
- CQMXPXDTNXHFFE-UHFFFAOYSA-N methyl 4-chloro-3-[5-[(3,5-difluoropyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2F)F)=C1 CQMXPXDTNXHFFE-UHFFFAOYSA-N 0.000 claims 1
- ORYPORMNFULBEL-UHFFFAOYSA-N methyl 4-chloro-3-[5-[(3-methylpyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound COC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2)C)=C1 ORYPORMNFULBEL-UHFFFAOYSA-N 0.000 claims 1
- SLOXFLKTCNMQSU-UHFFFAOYSA-N n-(2,6-difluorophenyl)-5-[2-ethyl-5-(trifluoromethyl)phenyl]thiophene-2-carboxamide Chemical compound CCC1=CC=C(C(F)(F)F)C=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 SLOXFLKTCNMQSU-UHFFFAOYSA-N 0.000 claims 1
- LBHGTPYMPASOAI-UHFFFAOYSA-N n-(2,6-difluorophenyl)-5-[2-methyl-5-(trifluoromethyl)phenyl]thiophene-2-carboxamide Chemical compound CC1=CC=C(C(F)(F)F)C=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 LBHGTPYMPASOAI-UHFFFAOYSA-N 0.000 claims 1
- NDSNELQVLUTLRF-UHFFFAOYSA-N n-(2,6-difluorophenyl)-5-[5-(furan-2-yl)-2-methoxypyridin-3-yl]thiophene-2-carboxamide Chemical compound COC1=NC=C(C=2OC=CC=2)C=C1C(S1)=CC=C1C(=O)NC1=C(F)C=CC=C1F NDSNELQVLUTLRF-UHFFFAOYSA-N 0.000 claims 1
- IUXQNLFKLUJFOW-UHFFFAOYSA-N n-(2,6-difluorophenyl)-5-[5-(furan-3-yl)-2-methoxypyridin-3-yl]thiophene-2-carboxamide Chemical compound COC1=NC=C(C2=COC=C2)C=C1C(S1)=CC=C1C(=O)NC1=C(F)C=CC=C1F IUXQNLFKLUJFOW-UHFFFAOYSA-N 0.000 claims 1
- LZQCXRBGAIZPSU-UHFFFAOYSA-N n-(3,5-difluoropyridin-4-yl)-5-[2-ethyl-5-(trifluoromethyl)phenyl]thiophene-2-carboxamide Chemical compound CCC1=CC=C(C(F)(F)F)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2F)F)S1 LZQCXRBGAIZPSU-UHFFFAOYSA-N 0.000 claims 1
- IAGOEFHSWWZIBS-UHFFFAOYSA-N n-(3,5-difluoropyridin-4-yl)-5-[2-methyl-5-(trifluoromethyl)phenyl]thiophene-2-carboxamide Chemical compound CC1=CC=C(C(F)(F)F)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2F)F)S1 IAGOEFHSWWZIBS-UHFFFAOYSA-N 0.000 claims 1
- DASXDCLBRXVGGF-UHFFFAOYSA-N n-(3,5-difluoropyridin-4-yl)-5-[5-(furan-2-yl)-2-methoxypyridin-3-yl]thiophene-2-carboxamide Chemical compound COC1=NC=C(C=2OC=CC=2)C=C1C(S1)=CC=C1C(=O)NC1=C(F)C=NC=C1F DASXDCLBRXVGGF-UHFFFAOYSA-N 0.000 claims 1
- AGYJVBRJNSFQOI-UHFFFAOYSA-N n-(3,5-difluoropyridin-4-yl)-5-[5-(furan-3-yl)-2-methoxypyridin-3-yl]thiophene-2-carboxamide Chemical compound COC1=NC=C(C2=COC=C2)C=C1C(S1)=CC=C1C(=O)NC1=C(F)C=NC=C1F AGYJVBRJNSFQOI-UHFFFAOYSA-N 0.000 claims 1
- RUHNBFUTTOPAGB-UHFFFAOYSA-N n-(3-fluoropyridin-4-yl)-5-[2-methyl-5-(trifluoromethyl)phenyl]thiophene-2-carboxamide Chemical compound CC1=CC=C(C(F)(F)F)C=C1C1=CC=C(C(=O)NC=2C(=CN=CC=2)F)S1 RUHNBFUTTOPAGB-UHFFFAOYSA-N 0.000 claims 1
- DUKQNODGMHRAAR-UHFFFAOYSA-N n-(3-fluoropyridin-4-yl)-5-[5-(furan-2-yl)-2-methoxypyridin-3-yl]thiophene-2-carboxamide Chemical compound COC1=NC=C(C=2OC=CC=2)C=C1C(S1)=CC=C1C(=O)NC1=CC=NC=C1F DUKQNODGMHRAAR-UHFFFAOYSA-N 0.000 claims 1
- DTLUVEHGHFVLKK-UHFFFAOYSA-N n-(3-fluoropyridin-4-yl)-5-[5-(furan-3-yl)-2-methoxypyridin-3-yl]thiophene-2-carboxamide Chemical compound COC1=NC=C(C2=COC=C2)C=C1C(S1)=CC=C1C(=O)NC1=CC=NC=C1F DTLUVEHGHFVLKK-UHFFFAOYSA-N 0.000 claims 1
- GSIKMDWORFZBHK-UHFFFAOYSA-N n-(3-methylpyridin-4-yl)-5-[2-methyl-5-(trifluoromethyl)phenyl]thiophene-2-carboxamide Chemical compound CC1=CN=CC=C1NC(=O)C1=CC=C(C=2C(=CC=C(C=2)C(F)(F)F)C)S1 GSIKMDWORFZBHK-UHFFFAOYSA-N 0.000 claims 1
- HITMRZCDQKQPRQ-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl]-3,5-difluoropyridine-4-carboxamide Chemical compound FC1=CN=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=NN=2)Cl)S1 HITMRZCDQKQPRQ-UHFFFAOYSA-N 0.000 claims 1
- PFNAMIILXMEDTB-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl]-3-fluoropyridine-4-carboxamide Chemical compound FC1=CN=CC=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=NN=2)Cl)S1 PFNAMIILXMEDTB-UHFFFAOYSA-N 0.000 claims 1
- MQXJKPNEOSDNNJ-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3-oxazol-2-yl)phenyl]thiophen-2-yl]-3,5-difluoropyridine-4-carboxamide Chemical compound FC1=CN=CC(F)=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=CN=2)Cl)S1 MQXJKPNEOSDNNJ-UHFFFAOYSA-N 0.000 claims 1
- PJCNFAKFDYEKIT-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3-oxazol-2-yl)phenyl]thiophen-2-yl]-3-fluoropyridine-4-carboxamide Chemical compound FC1=CN=CC=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=CN=2)Cl)S1 PJCNFAKFDYEKIT-UHFFFAOYSA-N 0.000 claims 1
- ZVFJVCLFOLOFQU-UHFFFAOYSA-N n-[5-[2-chloro-5-(1,3-oxazol-2-yl)phenyl]thiophen-2-yl]-3-methylpyridine-4-carboxamide Chemical compound CC1=CN=CC=C1C(=O)NC1=CC=C(C=2C(=CC=C(C=2)C=2OC=CN=2)Cl)S1 ZVFJVCLFOLOFQU-UHFFFAOYSA-N 0.000 claims 1
- XKCSACBZNUJQIR-UHFFFAOYSA-N n-[[5-[2-chloro-5-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-2,6-difluoroaniline Chemical compound FC1=CC=CC(F)=C1NCC1=CC=C(C=2C(=CC=C(C=2)C(F)(F)F)Cl)S1 XKCSACBZNUJQIR-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- ULLOLCOGLOVEJW-UHFFFAOYSA-N propyl 3-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]-4-methylbenzoate Chemical compound CCCOC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CC=CC=2F)F)=C1 ULLOLCOGLOVEJW-UHFFFAOYSA-N 0.000 claims 1
- RHHIWQKBUOFCJH-UHFFFAOYSA-N propyl 3-[5-[(3,5-difluoropyridin-4-yl)carbamoyl]thiophen-2-yl]-4-methylbenzoate Chemical compound CCCOC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2F)F)=C1 RHHIWQKBUOFCJH-UHFFFAOYSA-N 0.000 claims 1
- XZIQCGKMEVVBFQ-UHFFFAOYSA-N propyl 4-[5-[(2,6-difluorophenyl)carbamoyl]thiophen-2-yl]-3-methylbenzoate Chemical compound CC1=CC(C(=O)OCCC)=CC=C1C1=CC=C(C(=O)NC=2C(=CC=CC=2F)F)S1 XZIQCGKMEVVBFQ-UHFFFAOYSA-N 0.000 claims 1
- SCXRCDWGJSDYGZ-UHFFFAOYSA-N propyl 4-chloro-3-[5-[(3,5-difluoropyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound CCCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2F)F)=C1 SCXRCDWGJSDYGZ-UHFFFAOYSA-N 0.000 claims 1
- JVMLBUUWXUFVHQ-UHFFFAOYSA-N propyl 4-chloro-3-[5-[(3-methylpyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound CCCOC(=O)C1=CC=C(Cl)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2)C)=C1 JVMLBUUWXUFVHQ-UHFFFAOYSA-N 0.000 claims 1
- YTEPUVOPMKUXAZ-UHFFFAOYSA-N propyl 4-methyl-3-[5-[(3-methylpyridin-4-yl)carbamoyl]thiophen-2-yl]benzoate Chemical compound CCCOC(=O)C1=CC=C(C)C(C=2SC(=CC=2)C(=O)NC=2C(=CN=CC=2)C)=C1 YTEPUVOPMKUXAZ-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64677205P | 2005-01-25 | 2005-01-25 | |
| US60/646,772 | 2005-01-25 | ||
| PCT/US2006/002872 WO2006081389A1 (en) | 2005-01-25 | 2006-01-25 | Thiophene compounds for inflammation and immune-related uses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013003649A Division JP2013064019A (ja) | 2005-01-25 | 2013-01-11 | 炎症及び免疫に関連する用途に用いる化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008528519A JP2008528519A (ja) | 2008-07-31 |
| JP2008528519A5 true JP2008528519A5 (enExample) | 2013-03-07 |
| JP5221147B2 JP5221147B2 (ja) | 2013-06-26 |
Family
ID=36740852
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007552413A Expired - Fee Related JP5221147B2 (ja) | 2005-01-25 | 2006-01-25 | 炎症及び免疫に関連する用途に用いる化合物 |
| JP2013003649A Pending JP2013064019A (ja) | 2005-01-25 | 2013-01-11 | 炎症及び免疫に関連する用途に用いる化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013003649A Pending JP2013064019A (ja) | 2005-01-25 | 2013-01-11 | 炎症及び免疫に関連する用途に用いる化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8802721B2 (enExample) |
| EP (1) | EP1846388A4 (enExample) |
| JP (2) | JP5221147B2 (enExample) |
| AU (1) | AU2006208043B2 (enExample) |
| CA (1) | CA2595000C (enExample) |
| TW (1) | TWI444187B (enExample) |
| WO (1) | WO2006081389A1 (enExample) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006208045B2 (en) | 2005-01-25 | 2012-08-30 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| CA2640090A1 (en) * | 2006-01-25 | 2007-08-02 | Synta Pharmaceuticals Corp. | Substituted aromatic compounds for inflammation and immune-related uses |
| WO2007087443A2 (en) | 2006-01-25 | 2007-08-02 | Synta Pharmaceuticals Corp. | Vinyl-phenyl derivatives for inflammation and immune-related uses |
| JP2009528273A (ja) * | 2006-01-25 | 2009-08-06 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連使用用の置換ビアリール化合物 |
| CA2645434A1 (en) | 2006-03-20 | 2007-09-27 | Synta Pharmaceutical Corp. | Benzoimidazolyl-parazine compounds for inflammation and immune-related uses |
| US8779154B2 (en) * | 2006-09-26 | 2014-07-15 | Qinglin Che | Fused ring compounds for inflammation and immune-related uses |
| RU2465272C2 (ru) | 2007-09-10 | 2012-10-27 | КалсиМедика, Инк. | Соединения, моделирующие внутриклеточный кальций |
| WO2009076454A2 (en) * | 2007-12-12 | 2009-06-18 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US20110052643A1 (en) * | 2008-01-07 | 2011-03-03 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| CA2734500A1 (en) | 2008-08-27 | 2010-03-11 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
| US8524763B2 (en) * | 2008-09-22 | 2013-09-03 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| EP2350064A1 (en) * | 2008-10-01 | 2011-08-03 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| US8143269B2 (en) | 2008-10-03 | 2012-03-27 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| US8399436B2 (en) * | 2009-04-24 | 2013-03-19 | Glaxo Group Limited | N-pyrazolyl carboxamides as CRAC channel inhibitors |
| WO2010122088A1 (en) * | 2009-04-24 | 2010-10-28 | Glaxo Group Limited | Pyrazole and triazole carboxamides as crac channel inhibitors |
| MX2012002591A (es) | 2009-09-03 | 2012-04-02 | Allergan Inc | Compuestos como moduladores de tirosina cinasas. |
| US9340555B2 (en) | 2009-09-03 | 2016-05-17 | Allergan, Inc. | Compounds as tyrosine kinase modulators |
| US8618307B2 (en) * | 2009-09-16 | 2013-12-31 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US8377970B2 (en) | 2009-10-08 | 2013-02-19 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel |
| US8993612B2 (en) | 2009-10-08 | 2015-03-31 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| WO2011061340A1 (en) * | 2009-11-23 | 2011-05-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Inhibitors of the pp1/gadd34 complex for the treatment of a condition requiring an immunosuppressive activity |
| JP6112486B2 (ja) | 2010-04-27 | 2017-04-12 | カルシメディカ，インク． | 細胞内カルシウムを調節する化合物 |
| EP2563759B1 (en) | 2010-04-27 | 2022-04-06 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US10703722B2 (en) | 2010-04-27 | 2020-07-07 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| WO2011163198A2 (en) * | 2010-06-21 | 2011-12-29 | Board Of Regents, The University Of Texas System | Tg2 inhibitors and uses thereof |
| CN103180316A (zh) | 2010-08-27 | 2013-06-26 | 钙医学公司 | 调节细胞内钙的化合物 |
| US9333193B2 (en) * | 2010-09-20 | 2016-05-10 | University Of Virginia Patent Foundation | Compositions and methods for treating tuberculosis |
| AP3341A (en) * | 2010-10-30 | 2015-07-31 | Lupin Ltd | Oxazoline and isoxazoline derivatives as crac modulators |
| WO2012170931A2 (en) | 2011-06-10 | 2012-12-13 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| WO2013059677A1 (en) | 2011-10-19 | 2013-04-25 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| AU2013255441B2 (en) | 2012-05-02 | 2017-11-09 | Lupin Limited | Substituted pyrazole compounds as CRAC modulators |
| EP2844655A1 (en) | 2012-05-02 | 2015-03-11 | Lupin Limited | Substituted pyridine compounds as crac modulators |
| WO2014059333A1 (en) | 2012-10-12 | 2014-04-17 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
| US9725463B2 (en) | 2013-06-21 | 2017-08-08 | Lupin Limited | Substituted heterocyclic compounds as CRAC modulators |
| EP3013810A1 (en) | 2013-06-24 | 2016-05-04 | Lupin Limited | Chromane and chromene derivatives and their use as crac modulators |
| EP2848615A1 (en) | 2013-07-03 | 2015-03-18 | Almirall, S.A. | New pyrazole derivatives as CRAC channel modulators |
| CN104725347A (zh) * | 2015-02-11 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | 一类烷氧基取代的含甲氧苯基噻吩酰胺类结构的化合物及用途 |
| CN104725346A (zh) * | 2015-02-11 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | 一种腈基取代的甲氧苯噻吩酰胺类双靶点抑制剂及其用途 |
| TWI771269B (zh) | 2015-02-27 | 2022-07-21 | 美商鈣系醫藥公司 | 胰腺炎治療 |
| MY197231A (en) | 2015-07-22 | 2023-06-06 | Enanta Pharm Inc | Benzodiazepine derivatives as rsv inhibitors |
| CA2995094A1 (en) | 2015-08-07 | 2017-02-16 | Calcimedica, Inc. | Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury |
| CN108699077B (zh) * | 2016-01-15 | 2021-03-02 | 英安塔制药有限公司 | 作为rsv抑制剂的杂环化合物 |
| CN106008496B (zh) * | 2016-05-31 | 2018-06-19 | 华南农业大学 | S-(5-取代-1,3,4-噻二唑)-(5-取代苯基)-2-呋喃硫代甲酸酯类化合物及其制备方法和应用 |
| WO2018129287A1 (en) | 2017-01-06 | 2018-07-12 | Enanta Pharmaceuticals, Inc. | Heteroaryldiazepine derivatives as rsv inhibitors |
| WO2018152413A1 (en) | 2017-02-16 | 2018-08-23 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of benzodiazepine derivatives |
| WO2018226801A1 (en) | 2017-06-07 | 2018-12-13 | Enanta Pharmaceuticals, Inc. | Aryldiazepine derivatives as rsv inhibitors |
| WO2019006295A1 (en) * | 2017-06-30 | 2019-01-03 | Enanta Pharmaceuticals, Inc. | HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS |
| US10851115B2 (en) | 2017-06-30 | 2020-12-01 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
| ES3011633T3 (en) | 2017-08-31 | 2025-04-07 | Ahammune Biosciences Private Ltd | Thiophene compounds, process for synthesis and use thereof for the treatment of autoimmune disorders |
| CN111386118B (zh) | 2017-09-29 | 2023-05-09 | 英安塔制药有限公司 | 作为rsv抑制剂的组合药物剂 |
| WO2019094920A1 (en) | 2017-11-13 | 2019-05-16 | Enanta Pharmaceuticals, Inc. | Azepin-2-one derivatives as rsv inhibitors |
| MX394621B (es) | 2017-11-13 | 2025-03-24 | Enanta Pharm Inc | Procesos para la resolucion de los derivados de la benzodiazepina-2-ona y de la benzoazepin-2-ona |
| WO2019199908A1 (en) | 2018-04-11 | 2019-10-17 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
| JP2022508468A (ja) | 2018-09-14 | 2022-01-19 | ルヒゼン ファーマスティカルズ アクツィエンゲゼルシャフト | Ｃｒａｃ阻害剤およびコルチコステロイドを含む組成物ならびにそれらの使用方法 |
| WO2020190935A1 (en) | 2019-03-18 | 2020-09-24 | Enanta Pharmaceuticals, Inc. | Benzodiazepine derivatives as rsv inhibitors |
| US11179400B2 (en) | 2019-04-09 | 2021-11-23 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
| US11505558B1 (en) | 2019-10-04 | 2022-11-22 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
| PH12022550783A1 (en) | 2019-10-04 | 2023-07-31 | Enanta Pharm Inc | Antiviral heterocyclic compounds |
| US12486274B2 (en) | 2020-01-13 | 2025-12-02 | Verge Analytics, Inc. | Substituted pyrazolo-pyrimidines and uses thereof |
| UY39032A (es) | 2020-01-24 | 2021-07-30 | Enanta Pharm Inc | Compuestos heterocíclicos como agentes antivirales |
| US20230092377A1 (en) * | 2020-02-20 | 2023-03-23 | Industry-University Cooperation Foundation Hanyang University Erica Campus | Metal negative electrode, secondary battery comprising same, and method for producing same |
| CA3172249A1 (en) | 2020-03-20 | 2021-09-23 | Calcimedica, Inc. | Methods and compositions for treating acute lung injury and acute respiratory distress syndrome |
| WO2022010882A1 (en) | 2020-07-07 | 2022-01-13 | Enanta Pharmaceuticals, Inc, | Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors |
| WO2022086840A1 (en) | 2020-10-19 | 2022-04-28 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as anti-viral agents |
| JP7791898B2 (ja) | 2020-11-13 | 2025-12-24 | カルシメディカ，インク． | Ｃｒａｃチャネル阻害剤の合成の改善 |
| US12612412B2 (en) | 2021-02-26 | 2026-04-28 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
| AR129003A1 (es) | 2022-04-07 | 2024-07-03 | Enanta Pharm Inc | Compuestos heterocíclicos antivirales |
| WO2023211997A1 (en) | 2022-04-27 | 2023-11-02 | Enanta Pharmaceuticals, Inc. | Antiviral compounds |
| GB202300021D0 (en) * | 2023-01-03 | 2023-02-15 | Thirtyfivebio Ltd | Compounds |
| KR20250147900A (ko) * | 2024-04-01 | 2025-10-14 | 단국대학교 천안캠퍼스 산학협력단 | 신규 티오펜 유도체 및 이의 용도 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1548398A (en) * | 1975-06-05 | 1979-07-11 | Lilly Industries Ltd | Acylamino pyrroles furans and thiophenes |
| US4187232A (en) | 1975-06-05 | 1980-02-05 | Lilly Industries Limited | Acylamino derivatives |
| DE4233198A1 (de) * | 1992-10-02 | 1994-04-07 | Bayer Ag | Substituierte Thiophencarbonsäureamide |
| GB9424379D0 (en) * | 1994-12-02 | 1995-01-18 | Agrevo Uk Ltd | Fungicides |
| JP4385414B2 (ja) * | 1997-10-13 | 2009-12-16 | アステラス製薬株式会社 | アミド若しくはアミン誘導体 |
| US6652854B2 (en) * | 2000-08-08 | 2003-11-25 | Immunex Corporation | Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| JP2002338537A (ja) | 2001-05-16 | 2002-11-27 | Mitsubishi Pharma Corp | アミド化合物およびその医薬用途 |
| CN1596240A (zh) | 2001-12-19 | 2005-03-16 | 阿特罗吉尼克斯公司 | 查耳酮衍生物及其治疗疾病的用途 |
| GB0209715D0 (en) | 2002-04-27 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| DE10306250A1 (de) * | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US20060178403A1 (en) | 2003-03-07 | 2006-08-10 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| US7906537B2 (en) | 2003-03-21 | 2011-03-15 | H. Lundbeck A/S | Substituted p-diaminobenzene derivatives |
| US20040248957A1 (en) * | 2003-05-16 | 2004-12-09 | Ambit Biosciences Corporation | Heterocyclic compounds and uses thereof |
| NZ545447A (en) | 2003-07-23 | 2010-03-26 | Synta Pharmaceuticals Corp | Compounds for inflammation and immune-related uses |
| JP2007517843A (ja) | 2004-01-05 | 2007-07-05 | アストラゼネカ アクチボラグ | Ｃｈｋ１阻害剤であるチオフェン誘導体 |
| KR20070057965A (ko) | 2004-09-21 | 2007-06-07 | 신타 파마슈티칼스 코프. | 염증 및 면역 관련 용도를 위한 화합물 |
| GB0422057D0 (en) | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
| WO2006083477A2 (en) | 2005-01-07 | 2006-08-10 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| AU2006208045B2 (en) | 2005-01-25 | 2012-08-30 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| JP2009528273A (ja) | 2006-01-25 | 2009-08-06 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連使用用の置換ビアリール化合物 |
| AU2007211276B2 (en) | 2006-01-31 | 2013-06-06 | Synta Pharmaceuticals Corp. | Pyridylphenyl compounds for inflammation and immune-related uses |
| CA2645434A1 (en) | 2006-03-20 | 2007-09-27 | Synta Pharmaceutical Corp. | Benzoimidazolyl-parazine compounds for inflammation and immune-related uses |
| AU2007230911A1 (en) | 2006-03-23 | 2007-10-04 | Synta Pharmaceuticals Corp. | Benzimidazolyl-pyridine compounds for inflammation and immune-related uses |
| US8779154B2 (en) | 2006-09-26 | 2014-07-15 | Qinglin Che | Fused ring compounds for inflammation and immune-related uses |
| EP2086326B1 (en) | 2006-11-13 | 2014-01-08 | Synta Pharmaceuticals Corp. | Cyclohexenyl-aryl compounds for inflammation and immune-related uses |
| EP2129219A4 (en) | 2007-02-16 | 2012-08-29 | Synta Pharmaceuticals Corp | SUBSTITUTED FUSED CYCLE COMPOUNDS USED IN CASES OF INFLAMMATION OR IMMUNE DISORDERS |
| ES2440267T3 (es) | 2007-08-01 | 2014-01-28 | Synta Pharmaceuticals Corporation | Compuestos de heterociclo-arilo para la inflamación y usos inmunorrelacionados |
| EP2185514A4 (en) | 2007-08-01 | 2011-05-18 | Synta Pharmaceuticals Corp | VINYL-ARYL DERIVATIVES FOR INFLAMMATORY AND IMMUNE DISORDERS |
| TW200911800A (en) | 2007-08-01 | 2009-03-16 | Synta Pharmaceuticals Corp | Pyridine compounds for inflammation and immune-related uses |
| US8324219B2 (en) | 2007-09-20 | 2012-12-04 | Synta Pharmaceuticals Corp. | Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses |
| US20110052643A1 (en) | 2008-01-07 | 2011-03-03 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
-
2006
- 2006-01-25 WO PCT/US2006/002872 patent/WO2006081389A1/en not_active Ceased
- 2006-01-25 CA CA2595000A patent/CA2595000C/en not_active Expired - Fee Related
- 2006-01-25 JP JP2007552413A patent/JP5221147B2/ja not_active Expired - Fee Related
- 2006-01-25 US US11/340,292 patent/US8802721B2/en not_active Expired - Fee Related
- 2006-01-25 AU AU2006208043A patent/AU2006208043B2/en not_active Ceased
- 2006-01-25 TW TW095102770A patent/TWI444187B/zh not_active IP Right Cessation
- 2006-01-25 EP EP06719650A patent/EP1846388A4/en not_active Withdrawn
-
2013
- 2013-01-11 JP JP2013003649A patent/JP2013064019A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534124A5 (enExample) | ||
| JP2008528520A5 (enExample) | ||
| RU2006131132A (ru) | 1,3,5,-тризамещенные производные 4,5-дигидро-1н-пиразола, обладающие св1-антагонистической активностью | |
| JP2022515197A5 (enExample) | ||
| JP5221147B2 (ja) | 炎症及び免疫に関連する用途に用いる化合物 | |
| AU2016228207B2 (en) | Sigma ligands for the prevention or treatment of pain induced by chemotherapy | |
| JP2013508279A5 (enExample) | ||
| JP2002536445A5 (enExample) | ||
| JP2010527373A5 (enExample) | ||
| JP2009542699A5 (enExample) | ||
| JP2012504133A5 (enExample) | ||
| JP2013532652A5 (enExample) | ||
| JP2007508360A5 (enExample) | ||
| JP2020500866A5 (enExample) | ||
| JP2013529210A5 (enExample) | ||
| JP2010090138A5 (enExample) | ||
| JP2013532668A5 (enExample) | ||
| JP2004519469A5 (enExample) | ||
| JP2015504081A5 (enExample) | ||
| JP2009545600A5 (enExample) | ||
| JP2007520452A5 (enExample) | ||
| JP2014505107A5 (enExample) | ||
| JP2006501298A5 (enExample) | ||
| RU2006130000A (ru) | Органические соединения | |
| RU2014132564A (ru) | Хитозан, ковалентно связанный с низкомолекулярным антагонистом интегрина, для нацеленной доставки |